[Asia Economy Reporter Minwoo Lee] Anigen announced on the 13th that it has signed a "Supply Contract for Goods for Additional Indication Development Preclinical Trials of iCP-NI" worth 800 million KRW with Cellivery. This amount corresponds to 9.61% of last year's sales revenue.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing